# Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma

> **NCT01693315** · PHASE2 · COMPLETED · sponsor: **Amakem, NV** · enrollment: 82 (actual)

## Conditions studied

- Glaucoma
- Ocular Hypertension
- Eye Disease

## Interventions

- **DRUG:** AMA0076
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01693315
- **Lead sponsor:** Amakem, NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2013-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01693315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01693315, "Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01693315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*